A recombinant virus-like particle vaccine against adenovirus-7 induces a potent humoral response.

ABSTRACT: Adenoviruses (AdVs) cause infections in humans that range from mild to severe, and can cause outbreaks particularly in close contact settings. Several human AdV types have been identified, which can cause a wide array of clinical manifestations. AdV types 4 and 7 (AdV-4 and AdV-7), which are among the most commonly circulating types in the United States, are known to cause acute respiratory disease that can result in hospitalization and rarely, death. Currently, the only vaccines approved for use in humans are live virus vaccines against AdV-4 and AdV-7, though these vaccines are only authorized for use in U.S. military personnel. While they are efficacious, use of these live virus vaccines carries considerable risks of vaccine-associated viral shedding and recombination. Here, we present

SUBMITTER: Mazboudi R 

PROVIDER: S-EPMC10567840 | biostudies-literature | 2023 Oct

REPOSITORIES: biostudies-literature